Concord Drugs

Concord Drugs Ltd Half Yearly Results

NSEBSE

₹31.5

(1.25%)

May 30, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Mar-2025	Sept-2024	Mar-2024	Sept-2023	Mar-2023
Gross Sales	21.19	24.05	28.43	16.5	25.83
Excise Duty	0	0	0	0	0
Net Sales	21.19	24.05	28.43	16.5	25.83
Other Operating Income	0	0.01	0	0.01	0
Other Income	0	0	0	0	0
Total Income	21.2	24.06	28.43	16.51	25.84
Total Expenditure	18.76	22.36	27.45	13.43	23.42
PBIDT	2.44	1.71	0.98	3.07	2.41
Interest	1.11	0.92	1	0.87	0.95
PBDT	1.33	0.79	-0.02	2.2	1.47
Depreciation	0.75	0.68	0.78	0.77	0.71
Minority Interest Before NP	0	0	0	0	0
Tax	0.15	0.05	-0.2	0.42	0.22
Deferred Tax	0.17	-0.02	-0.02	-0.04	-0.08
Reported Profit After Tax	0.27	0.07	-0.58	1.05	0.62
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	0.27	0.07	-0.58	1.05	0.62
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	0.27	0.07	-0.58	1.05	0.62
EPS (Unit Curr.)	0.27	0.07	0	1.13	0.66
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	10	10	10	9.32	9.32
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	11.51	7.11	3.44	18.6	9.33
PBDTM(%)	-	-	-	-	-
PATM(%)	1.27	0.29	-2.04	6.36	2.4

No Record Found

Invest wise with Expert advice